From cancer genomics to precision oncology - Tissue's still an issue

22Citations
Citations of this article
160Readers
Mendeley users who have this article in their library.

Abstract

Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy material, thereby facilitating the broader implementation of personalized cancer medicine. However, genomics-based patient stratification across diverse tumor types is unlikely to supplant tissue-of-origin considerations in addressing clinical needs, including the development and application of novel "rationally targeted" cancer therapies. © 2014 Elsevier Inc.

Cite

CITATION STYLE

APA

Cohen, R. L., & Settleman, J. (2014, June 19). From cancer genomics to precision oncology - Tissue’s still an issue. Cell. Cell Press. https://doi.org/10.1016/j.cell.2014.05.027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free